Skip to main content
. 2020 Oct 7;46:147. doi: 10.1186/s13052-020-00914-4

Table 3.

Demographic, perinatal and neonatal characteristics of the study population by LCs

Class 1 Class 2 Class 3 P-value
n = 14 n = 309 n = 78
Age at hospitalization (≥6 months) 0 (0.00) 34 (11.26) 78 (100.00) < 0.001
Gestational age, weeks 38.79 (1.97) 38.23 (3.02) 38.23 (2.27) 0.775
Birth weight, Kg 3.05 (0.48) 3.10 (0.60) 2.97 (0.60) 0.339
Singleton delivery 14 (100.00) 301 (97.41) 75 (96.15) 0.678
Type of delivery 0.534
 Elective caesarean section 4 (28.57) 91 (31.71) 18 (25.35)
 Emergency caesarean section 2 (14.29) 29 (10.10) 12 (16.90)
 Vaginal 8 (57.14) 167 (58.19) 41 (57.75)
O2 therapy at birth 2 (14.29) 22 (7.12) 9 (11.54) 0.314
Resuscitation 1 (7.14) 15 (4.85) 7 (8.97) 0.366
Surfactant at birth 0 (0.00) 3 (0.97) 1 (1.28) 0.902
Neonatal hospitalization 2 (14.29) 38 (12.30) 7 (8.97) 0.685
Mechanical ventilation 1 (7.14) 7 (2.27) 3 (3.85) 0.441
First-born 4 (28.57) 121 (39.16) 37 (47.44) 0.271
Number of siblings 0.93 (0.83) 0.96 (1.13) 0.73 (0.91) 0.256
Number of cohabitants 3.64 (1.45) 3.79 (1.26) 3.55 (1.35) 0.322
Birth within 3 months of the epidemic season start 3 (21.43) 15 (4.85) 4 (5.13) 0.028
Breastfeeding (exclusively) 1 (9.09) 79 (35.75) 28 (48.28) 0.113
Breastfeeding duration, months 0.21 (0.80) 0.48 (1.63) 1.18 (2.04) 0.004
Palivizumab prophylaxis 0 (0.00) 2 (0.64) 0 (0.00)
Hypertonic saline 1 (7.14) 5 (1.62) 0 (0.00) 0.120
Inhaled bronchodilators 6 (42.86) 157 (50.81) 46 (58.97) 0.339
Inhaled corticosteroids 9 (64.29) 233 (75.40) 66 (84.62) 0.120
Systemic corticosteroids 12 (85.71) 282 (91.26) 55 (70.51) < 0.001
Systemic antibiotics 7 (50.00) 203 (65.70) 63 (80.77) 0.013
Low-flow oxygen therapy 6 (42.86) 144 (46.60) 24 (30.77) 0.042
Length of hospital stay 9.21 (7.93) 7.75 (18.42) 5.17 (3.10) 0.415
Intensive care admission 2 (14.29) 38 (12.30) 7 (8.97) 0.685

Data are presented as n (%) or mean (SD)